{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:06:53Z","timestamp":1788941213386,"version":"build-2803163510"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-026-00919-x","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:31:24Z","timestamp":1788939084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expansion of the allelic and phenotypic spectrum of MED25-related developmental disorder: novel compound heterozygous variants with structural domain implications"],"prefix":"10.1007","volume":"27","author":[{"given":"Camilo Andr\u00e9s","family":"Yidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataly Alejandra","family":"Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asid","family":"De Jes\u00fas Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Porras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"919_CR1","doi-asserted-by":"crossref","unstructured":"Basel-Vanagaite L, Smirin-Yosef P, Essakow JL, Tzur S, Lagovsky I, Maya I et al (2015) Homozygous MED25 mutation implicated in eye\u2013intellectual disability syndrome. Hum Genet 134(5):577\u2013587. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25792360\/","DOI":"10.1007\/s00439-015-1541-x"},{"key":"919_CR2","unstructured":"Online Mendelian Inheritance in Man (OMIM\u00ae) MED25-mediated developmental disorder; entry no. 610197 Baltimore (MD): Johns Hopkins University; 2025 [cited 2025 Dec 17]. Available from: https:\/\/www.omim.org\/entry\/610197"},{"key":"919_CR3","doi-asserted-by":"crossref","unstructured":"Maini I, Errichiello E, Caraffi SG, Rosato S, Bizzarri V, Pollazzon M et al (2020) Improving the phenotype description of Basel-Vanagaite-Smirin-Yosef syndrome, MED25-related: polymicrogyria as a distinctive neuroradiological finding. Eur J Med Genet 63(11):104055. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32816121\/","DOI":"10.1007\/s10048-020-00625-2"},{"key":"919_CR4","unstructured":"UniProt Consortium, UniProtKB MED25 (Q71SY5). 2025 [cited 2025 Dec 17]. Available from: https:\/\/www.uniprot.org\/uniprotkb\/Q71SY5\/entry"},{"key":"919_CR5","doi-asserted-by":"publisher","unstructured":"Yang F, DeBeaumont R, Zhou S, Naar AM (2004) The activator-recruited cofactor\/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator. Proc Natl Acad Sci U S A 101(8):2339\u20132344. Available from: https:\/\/www.pnas.org\/doi\/full\/https:\/\/doi.org\/10.1073\/pnas.0308676100","DOI":"10.1073\/pnas.0308676100"},{"issue":"1","key":"919_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jsb.2010.10.011","volume":"174","author":"F Bontems","year":"2011","unstructured":"Bontems F, Verger A, Dewitte F, Lens Z, Baert JL, Ferreira E et al (2011) NMR structure of the human Mediator MED25 ACID domain. J Struct Biol 174(1):245\u2013251. https:\/\/doi.org\/10.1016\/j.jsb.2010.10.011","journal-title":"J Struct Biol"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-026-00919-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-026-00919-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-026-00919-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:31:27Z","timestamp":1788939087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-026-00919-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":6,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["919"],"URL":"https:\/\/doi.org\/10.1007\/s10048-026-00919-x","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"6 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki and relevant national legislation in the field of human research. The patient\u2019s clinical and genetic assessment took place as part of routine medical care. Written consent for genetic testing was obtained from the patient\u2019s legal guardians before whole-exome sequencing. Additionally, written informed consent for the publication of anonymized clinical information and identifiable photographs was obtained from their legal guardians. Since this report is a single-patient case study without any experimental intervention and contains completely anonymized data, following local guidelines for regulatory processes, formal institutional review board approval was not necessary.The data in this manuscript is de-identified to protect patient confidentiality.","order":1,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"69"}}